Australia markets closed

Neuren Pharmaceuticals Limited (NEU.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
19.70+0.52 (+2.71%)
At close: 04:10PM AEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from investing activities
Investments in property, plant and equipment
-27
-40
-19
-10
-6
Purchases of investments
-
-211,445
-
-
-
Net cash used for investing activities
-27
-211,485
-19
-10
-6
Cash flows from financing activities
Common stock issued
-
3,637
-
23,281
20,216
Common stock repurchased
-7
-18
-2
-1,106
-1,075
Net cash used provided by (used for) financing activities
1,097
3,619
-2
22,175
19,141
Net change in cash
55,363
-22,941
3,578
12,195
11,057
Cash at beginning of period
31,088
40,180
36,783
24,188
13,844
Cash at end of period
86,451
17,094
40,180
36,783
24,188
Free cash flow
Capital expenditure
-27
-40
-19
-10
-6
Free cash flow
54,266
184,885
3,580
-9,980
-8,084